These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8840655)
1. Antifungal susceptibility pattern of non-albicans Candida species & distribution of species isolated from Candidaemia cases over a 5 year period. Chakrabarti A; Ghosh A; Batra R; Kaushal A; Roy P; Singh H Indian J Med Res; 1996 Aug; 104():171-6. PubMed ID: 8840655 [TBL] [Abstract][Full Text] [Related]
2. Change in distribution & antifungal susceptibility of Candida species isolated from candidaemia cases in a tertiary care centre during 1996-2000. Chakrabarti A; Mohan B; Shrivastava SK; Marak RS; Ghosh A; Ray P Indian J Med Res; 2002 Jul; 116():5-12. PubMed ID: 12514972 [TBL] [Abstract][Full Text] [Related]
3. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures]. Ozcan SK; Mutlu B; Dündar D; Willke A Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961 [TBL] [Abstract][Full Text] [Related]
4. Candidemia and the susceptibility pattern of Candida isolates in blood. Osoba AO; Al-Mowallad AW; McAlear DE; Hussein BA Saudi Med J; 2003 Oct; 24(10):1060-3. PubMed ID: 14578968 [TBL] [Abstract][Full Text] [Related]
5. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)]. Durán MT; Velasco D; Canle D; Moure R; Villanueva R Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381 [TBL] [Abstract][Full Text] [Related]
6. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data. Samonis G; Kofteridis DP; Saloustros E; Giannopoulou KP; Ntziora F; Christidou A; Maraki S; Falagas ME Scand J Infect Dis; 2008; 40(5):414-9. PubMed ID: 18418802 [TBL] [Abstract][Full Text] [Related]
7. The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study. Tan TY; Tan AL; Tee NW; Ng LS; Chee CW Mycoses; 2010 Nov; 53(6):515-21. PubMed ID: 19619263 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of candidemia in a Turkish tertiary care hospital. Bakir M; Cerikcioglu N; Barton R; Yagci A APMIS; 2006 Sep; 114(9):601-10. PubMed ID: 16948812 [TBL] [Abstract][Full Text] [Related]
10. Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in São Paulo, Brazil, 1995-2003. da Matta DA; de Almeida LP; Machado AM; Azevedo AC; Kusano EJ; Travassos NF; Salomão R; Colombo AL Diagn Microbiol Infect Dis; 2007 Apr; 57(4):399-404. PubMed ID: 17240110 [TBL] [Abstract][Full Text] [Related]
11. Microbial profile and drug resistance of Candida strains isolated from the blood of children: an 11-year study. Małafiej E; Adamiec AC; Tworzyańska U Mycoses; 2009 Mar; 52(2):149-53. PubMed ID: 18627468 [TBL] [Abstract][Full Text] [Related]
12. Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern? Oxman DA; Chow JK; Frendl G; Hadley S; Hershkovitz S; Ireland P; McDermott LA; Tsai K; Marty FM; Kontoyiannis DP; Golan Y J Antimicrob Chemother; 2010 Jul; 65(7):1460-5. PubMed ID: 20430790 [TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of oral Candida to seven antifungal agents. Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594 [TBL] [Abstract][Full Text] [Related]
14. Incidence and antifungal susceptibility of Candida species in neonatal septicemia. Vinod Kumar CS; Neelagund YF J Commun Dis; 2004 Sep; 36(3):182-6. PubMed ID: 16509255 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G; J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683 [TBL] [Abstract][Full Text] [Related]
16. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre. Quindós G; Sánchez-Vargas LO; Villar-Vidal M; Eraso E; Alkorta M; Hernández-Almaraz JL Int J Antimicrob Agents; 2008 Mar; 31(3):266-71. PubMed ID: 18054468 [TBL] [Abstract][Full Text] [Related]
17. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals. Zaoutis TE; Foraker E; McGowan KL; Mortensen J; Campos J; Walsh TJ; Klein JD Diagn Microbiol Infect Dis; 2005 Aug; 52(4):295-8. PubMed ID: 15922535 [TBL] [Abstract][Full Text] [Related]
18. Role of yeasts as nosocomial pathogens & their susceptibility to fluconazole & amphotericin B. Prasad KN; Agarwal J; Dixit AK; Tiwari DP; Dhole TN; Ayyagari A Indian J Med Res; 1999 Jul; 110():11-7. PubMed ID: 10709333 [TBL] [Abstract][Full Text] [Related]
19. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey. Kuzucu C; Durmaz R; Otlu B; Aktas E; Gulcan H; Cizmeci Z New Microbiol; 2008 Jul; 31(3):401-8. PubMed ID: 18843896 [TBL] [Abstract][Full Text] [Related]
20. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use]. Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]